SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. 

The group generates a revenue of 1.4 MM€ and operates 24 manufacturing plants and 10 R&D centers in Europe, North America and Asia. 3,400 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.

SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.


Pharmaceutical

SEQENS

Pierre Luzeau

Audrey Bronkhorst

Jeanne Rimaud

Desislava Tsekova

Delphine Blino

Andrew Purvis

Véronique Fromont

Ronan Rocle

Kathleen Reversé

Charlie S.

Alexandra Nowak

Emmanuelle Morandi

Vincent Milhau

Julien Boutet

Jean-Louis Martin

Victor Z.

Robert Monti

Alexandre Gultzgoff

Cedric Ducros

Sales and Marketing

Leadership Team

Management Team

Business Development

Procurement and Operations Team

Quality Assurance and Regulatory Team

Research and Development

Human Resources Team

Teams at SEQENS